Skip to content

Mesa Laboratories MLAB Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Personalis, Inc. logo
Personalis, Inc.PSNL
-$21K-106%
ICU Medical logo
ICU MedicalICUI
-$2.99M+67.6%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
STERIS logo
STERISSTE
Charles River Laboratories logo
Charles River LaboratoriesCRL
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Mesa Laboratories’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's other noncash income (expense)?
Mesa Laboratories (MLAB) reported other noncash income (expense) of -$1.26M in Q4 2025.
How has Mesa Laboratories's other noncash income (expense) changed year-over-year?
Mesa Laboratories's other noncash income (expense) increased by 40.8% year-over-year, from -$2.13M to -$1.26M.
What does other noncash income (expense) mean?
This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.